OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 60 years old
- You have completed at least 9 years of education
- You have been diagnosed with OCD using a standard clinical interview called the MINI
- Your OCD symptoms are at a moderate level or above, based on a standard OCD rating scale (called the Y-BOCS, with a score of 16 or higher)
- You are either not taking any medication, or you have been on the same stable medication for at least 8 weeks before joining and are willing to keep taking the same medication throughout the study
- Having anxiety or mild to moderate depression related to your OCD does not automatically disqualify you
Who may not be able to join:
- You have a serious medical condition, neurological illness, or another psychiatric disorder besides OCD
- Your OCD symptoms are so severe that completing the required assessments and examinations would not be possible
- You are considered to be at serious risk of suicide
- You are pregnant or planning to become pregnant
- You are currently taking anti-seizure (antiepileptic) medication
- You have significant physical health problems or abnormal results on medical tests that are considered clinically important (confirm with trial site)
- You have already completed a full course of a talking therapy called CBT or ERP (a specific type of therapy focused on facing fears and resisting compulsions)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhen Wang, PhD, MD, Shanghai Mental Health Center
Phone: +86 34773516
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To explore the differences in treatment efficacy between active and sham transcranial alternating current stimulation (tACS) concurrent with exposure and response prevention (ERP)(tACS+ERP) in patients with obsessive-compulsive disorder (OCD).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.